Pure Global

Calisthenics Versus High Intensity Interval Training in NAFL - Trial NCT06032650

Access comprehensive clinical trial information for NCT06032650 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06032650
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06032650
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Calisthenics Versus High Intensity Interval Training in NAFL
Calisthenics Versus High-intensity Interval Exercises on Health-related Outcomes in Patients With Non-alcoholic Fatty Liver

Study Focus

Calisthenics exercise and High intensity interval training

Interventional

other

Sponsor & Location

Cairo University

Timeline & Enrollment

N/A

Oct 01, 2023

Nov 01, 2024

60 participants

Primary Outcome

Liver ultrasound parameters,Blood lipid profile

Summary

According to sample size calculation and after achieving the inclusion criteria, sixty
 patients with non-alcoholic fatty liver (NAFL) of both genders will be enrolled in this study
 and their ages will be ranged from30s-40s; they will be selected from internal
 medicine-outpatient clinics, Cairo University Hospitals; they will participate in the study
 for 8 weeks, and randomly be assigned into two equal groups in number.
 
 Group (A) (n =30) will receive calisthenics exercise three times /week for eight weeks, group
 (B) (n =30) will receive HIIT for three times /week for eight weeks and all patients in both
 groups will receive their prescribed medication (Statin 5mg ).

ICD-10 Classifications

Alcoholic fatty liver
Alcoholic liver disease, unspecified
Alcoholic liver disease
Liver disease, unspecified
Alcoholic cirrhosis of liver

Data Source

ClinicalTrials.gov

NCT06032650

Non-Device Trial